Skip to main content
Non-financial boards have been closed.

Non-financial boards have been closed but will continue to be accessible in read-only form. If you're disappointed, we understand. Thank you for being an active participant in this community. We have more community features in development that we look forward to sharing soon. | The Motley Fool Community
Message Font: Serif | Sans-Serif
No. of Recommendations: 3
Losing weight is one of best things people with type 2 diabetes can do to manage their disease, and now new research suggests that a widely prescribed weight loss drug can help people do this better than diet and exercise alone.

As people get heavier and less active, their insulin levels rise. They are on the way to diabetes, heart disease -- and colon cancer, a new study shows.

A novel drug designed to slow or even stop the progression of type 1 diabetes is showing promise in its first limited human trials. Eighteen months after treatment with the experimental drug Diamyd, a small group of patients was better able to produce insulin than patients who did not receive the drug.

Who overate last night but with chicken, not steak, and then worked it off today...
Print the post  


What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.